David Hering - Sep 1, 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Executive Officer, Director
Signature
/s/ Jill Andersen attorney-in-fact for David Hering
Stock symbol
IVVD
Transactions as of
Sep 1, 2022
Transactions value $
$36,160
Form type
4
Date filed
9/1/2022, 04:28 PM
Previous filing
Jul 6, 2022
Next filing
Dec 16, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IVVD Common Stock Purchase $36.2K +8K $4.52 8K Sep 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average purchase price. The prices actually paid ranged from $4.515 to $4.52. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.